文献速递泌尿生殖技术与安全PETMR

68Ga-PSMA-PET:在前列腺癌检查中相较于当前胆碱PET与mpMRI应用的价值与未来展望

68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer.
PubMed 文献 · Radiol Med · 2018-08-16

本文综述了68Ga-PSMA PET/CT或PET/MRI在前列腺癌病程各阶段的主要适应症与未来发展,并与mpMRI和胆碱PET的当前应用进行比较;同时简要概述了有前景的18F标记PSMA示踪剂及PSMA放射性核素治疗的当前应用。

要点

  • 68Ga-PSMA通过评估PSMA表达成像,其敏感度和特异度优于11C/18F标记氟胆碱等脂质代谢示踪剂。
  • 在诊疗一体化时代,该示踪剂不仅用于成像,也用于治疗目的。
  • 综述按疾病临床病程梳理68Ga-PSMA PET/CT或PET/MRI的主要适应症与未来发展。

核心结论

  • 68Ga-PSMA因敏感度和特异度优于脂质代谢示踪剂而受到快速关注,并在诊疗一体化中兼具成像与治疗应用价值。

研究设计与样本

  • 综述文章,旨在概述68Ga-PSMA成像(PET/CT或PET/MRI)的主要适应症与未来发展,并简要概述有前景的18F标记PSMA示踪剂及PSMA放射性核素治疗的当前应用。

诊断标准与关键数值

  • 68Ga-PSMA的敏感度和特异度优于11C/18F标记氟胆碱等脂质代谢示踪剂。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Positron emission tomography (PET) has been commonly and successfully used, in combination with computed tomography (CT) and more recently magnetic resonance (MRI), in the workup of intermediate or high-risk prostate cancer (PCa). Nowadays, new specific receptor targeted PET tracers in prostate cancer imaging have been introduced; one of the most used is 68Ga-PSMA, that evaluates the expression of prostate-specific membrane antigen (PSMA). This tracer has been rapidly taken into account for its better sensitivity and specificity compared to lipid metabolism tracers, such as 11C/18F labelled fluorocholine. Besides, in the era of theranostics, this tracer is having a useful application not only for imaging but also for therapeutic purposes. The aim of this review article is, in the first part, to give an overview of the main indications and future development of 68Ga-PSMA imaging, using PET/CT or PET/MRI, according to the clinical course of the disease and in view of the current use of multiparametric MRI (mpMRI) and choline PET in the management of PCa. In the second part, a brief overview of the promising 18F-labelled PSMA tracers and the current use of PSMA radionuclide therapy will be provided.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Malaspina S, De Giorgi U, Kemppainen J, et al. 68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer. Radiol Med. 2018. PMID: 30116970. doi:10.1007/s11547-018-0929-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。